APR-246 activates transcription of p53 target genes, induces apoptosis, and suppresses growth of human cancer xenografts in a mutant p53-dependent manner [131,132,133] and synergizes with other chemotherapeutic drugs [134,135,136]. The gene discussed is TP53; the disease is cancer.